“…In competitive transplantation assays, a rigorous test for both self-renewal and multipotency during which donor HSCs are co-injected with wild-type bone marrow and assessed for their ability to regenerate all blood lineages, aged HSCs shows defect in long-term reconstitution of the immune system (Sudo et al, 2000;Kamminga et al, 2005;Rossi et al, 2005;Chambers et al, 2007). Aged HSCs also give rise to more cells of myeloid lineage at the expense of lymphoid fates (Sudo et al, 2000;Kim et al, 2003;Rossi et al, 2005;Cho et al, 2008;Guerrettaz et al, 2008). This myeloid bias in aging HSC populations has been explained by alterations in the subcomposition of the HSC pool, which is thought to contain clones with pre-determined differentiation bias (Dykstra et al, 2007;Cho et al, 2008;Beerman et al, 2010a;Morita et al, 2010).…”